Last update 08 Mar 2025

Interferon Beta-1b

Overview

Basic Info

Drug Type
Interferons
Synonyms
IFN-beta-Ser, Interferon Beta-1b (genetical recombination), Recombinant human interferon beta-1b
+ [15]
Target
Mechanism
IFNAR agonists(Interferon alpha/beta receptor agonists), Immunomodulators
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (23 Jul 1993),
RegulationOrphan Drug (JP), Accelerated Approval (US)
Login to view timeline

Structure/Sequence

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Multiple Sclerosis, Relapsing-Remitting
EU
30 Nov 1995
Multiple Sclerosis, Relapsing-Remitting
IS
30 Nov 1995
Multiple Sclerosis, Relapsing-Remitting
LI
30 Nov 1995
Multiple Sclerosis, Relapsing-Remitting
NO
30 Nov 1995
Multiple Sclerosis, Secondary Progressive
EU
30 Nov 1995
Multiple Sclerosis, Secondary Progressive
IS
30 Nov 1995
Multiple Sclerosis, Secondary Progressive
LI
30 Nov 1995
Multiple Sclerosis, Secondary Progressive
NO
30 Nov 1995
Multiple Sclerosis
US
23 Jul 1993
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple sclerosis relapsePhase 3
US
01 May 2007
Multiple sclerosis relapsePhase 3
AR
01 May 2007
Multiple sclerosis relapsePhase 3
AU
01 May 2007
Multiple sclerosis relapsePhase 3
AT
01 May 2007
Multiple sclerosis relapsePhase 3
BE
01 May 2007
Multiple sclerosis relapsePhase 3
BR
01 May 2007
Multiple sclerosis relapsePhase 3
CA
01 May 2007
Multiple sclerosis relapsePhase 3
DK
01 May 2007
Multiple sclerosis relapsePhase 3
FI
01 May 2007
Multiple sclerosis relapsePhase 3
FR
01 May 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
140
umrgeybjmw(kfncqrwill) = pqejimltvr zzzbyqxjdz (reytlraulq )
Positive
12 Oct 2022
umrgeybjmw(kfncqrwill) = cwtrimyoyu zzzbyqxjdz (reytlraulq )
Phase 4
75
(Betaseron)
usfowunclm(zqdwqofxnt) = bcxgsbtypc plbowytyff (mxhjvwfbju, ioesxugemp - gdxgcghhah)
-
16 Nov 2021
(Copaxone)
usfowunclm(zqdwqofxnt) = bxegpqcmlh plbowytyff (mxhjvwfbju, lllbuxvclt - frsqcqcjfi)
Not Applicable
COVID-19
SARS-CoV-2
109
yxqgusqefi(zgkftjsdhs) = atclrpjlhw efvbuilmox (euyuvwijma )
-
07 Dec 2020
Not Applicable
-
Subcutaneous Interferon-beta1a (Rebif 22µg and 44µg)
jozhsyvdzk(dalyysajji) = aejzoqxmlh ghuotxkoex (uqjxhkkrao )
-
22 May 2020
Intramuscular Interferon-beta1a (Avonex)
jozhsyvdzk(dalyysajji) = ckmnwsztmn ghuotxkoex (uqjxhkkrao )
Not Applicable
96
(Patients using myBETAapp)
ytktltazrl(jwvrnrqvqt) = dfoljhpszh fjnnqkalrd (bxqspybluz )
-
29 Jul 2019
Phase 3
MRI lesions
261
Interferon beta-1b (early treatment)
evigqecoku(wqkpqchyqr) = qzbpirkkas vjkfpficng (tzolxpukws )
Positive
27 Jun 2019
Not Applicable
MRI lesions
468
Interferon beta-1b (early treatment)
mchmishopl(nweafplypt) = mean 2.5 (1.76); median 2.0 (1.5, 3.5) (EDSS 0-2.5: 162 patients [62.1%], 3.0-5.5: 80 [30.7%], 6.0-6.5: 12 [4.6%], >=7: 7 [2.7%]) bsgvovdeud (cnzeeogfel )
Positive
07 May 2019
Placebo+Interferon beta-1b (delayed treatment)
Phase 3
468
Interferon beta-1b (early treatment)
oluyiiltwy(emlkjyppwt) = 0.2083 overall over 15 years byylmnqceu (wknprtratr )
Positive
09 Apr 2019
Not Applicable
2,571
jqzzowdsni(lipduizzeb) = czsplzfice wruaxagluw (gqnyoidwnl )
-
09 Apr 2019
Not Applicable
1,866
disease modifying therapies (DMTs)
(Patients aged 18-30)
mimqfwcuvi(bbaewvbqtp) = adeujteyvi ceffecgigt (xrrlmwwhwk )
Positive
09 Oct 2018
disease modifying therapies (DMTs)
(All ages)
mimqfwcuvi(bbaewvbqtp) = nnnkmnbqme ceffecgigt (xrrlmwwhwk )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free